Fluorodeoxyglucose whole-body positron emission tomography in colorectal cancer patients studied in routine daily practice

Diseases of the Colon and Rectum

Volumn 40, Issue 10, 1997, Pages 1195-1204

  Ruhlmann, Juergen ^a,c   Schomburg, Axel ^a   Bender, Hans ^a   Oehr, Peter ^a   Robertz Vaupel, Gerda Marie ^b   Vaupel, Hans ^b   Wolter, Hartmud ^a   Kozak, Beate ^a   Biersack, Hans Juergen ^a  

^a UNIVERSITY OF BONN   (Germany)

^b Institute for Medicine and Oncology   (Germany)

^c PET Center Bonn   (Germany)

Author keywords

Colorectal cancer; Fluorine 18 fluorodeoxyglucose; Positron emission tomography

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL ARTICLE; CLINICAL TRIAL; COLORECTAL CANCER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HUMAN; INTERMETHOD COMPARISON; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; FALSE POSITIVE REACTIONS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM RECURRENCE, LOCAL; SENSITIVITY AND SPECIFICITY; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0030863319     PISSN: 00123706     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02055166     Document Type: Article

References (10)

1. Jensen OM, Esteve J, Moller H, Renard H. Cancer in the European community and its member states. Eur J Cancer 1990;26:1167-256.
2. Strauss LG, Corius JH, Schlag P. Recurrence of colorectal tumors: PET evaluation. Radiology 1989;170:329-32.
3. Ito K, Kato T, Tadokoro M. Recurrent rectal cancer and scar differentiation with PET and MR imaging. Radiology 1992;182:549-52.
4. Haberkorn U, Strauss LG, Dimitrakopoulou A. PET studies of FDG metabolism in patients with recurrent colorectal tumors receiving radiotherapy. J Nucl Med 1991;32:1485-90.
5. Pounds TR, Valk PE, Haseman MK. Whole-body PET imaging in diagnosis of recurrent colorectal cancer [abstract]. J Nucl Med 1995;36:57P.
6. Dahlbom M, Huffman EJ, Hoh CK, et al. Whole body PET: part I. Methods and performance characteristics. J Nucl Med 1992;33:1191-9.
7. Schiepers C, Penninckx F, De Vadder N, et al. Contribution of PET in the diagnosis of recurrent colorectal cancer: comparison with conventional imaging. Eur J Surg Oncol 1995;21:517-22.
8. Falk PM, Gupta NC, Thorson AG, et al. Positron emission tomography for preoperative staging of colorectal carcinoma. Dis Colon Rectum 1994;37:153-6.
9. Gambhir SS, Hoh CK, Phelps ME, Madar I, Maddahi J. Decision tree sensitivity analysis for cost-effectiveness of FDG-PET in the staging and management of non-small-cell lung carcinoma. J Nucl Med 1996;37:1428-36.
10. Valk PE, Pounds TR, Tesar RD, Hopkins DM, Haseman MK. Cost-effectiveness of PET imaging in clinical oncology. Nucl Med Biol 1996;23:737-43.